Safety of contraceptive methods for women with rheumatoid arthritis: a systematic review

Contraception

Volumn 82, Issue 1, 2010, Pages 64-71

  Farr, Sherry L ^a   Folger, Suzanne G ^a   Paulen, Melissa E ^a   Curtis, Kathryn M ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Contraception; Estrogen; Oral contraceptives; Progesterone; Progestins; Rheumatoid arthritis

Indexed keywords

ESTROGEN; ETHINYLESTRADIOL PLUS LYNESTRENOL; GESTAGEN; MEDROXYPROGESTERONE ACETATE; MESTRANOL PLUS NORETYNODREL; PROGESTERONE;

CLINICAL TRIAL; DISEASE COURSE; FEMALE; HORMONAL CONTRACEPTION; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MEDLINE; ORAL CONTRACEPTION; PATIENT SAFETY; PUBLICATION; QUALITY CONTROL; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMATIC REVIEW; WOMEN'S HEALTH;

ADULT; ARTHRITIS, RHEUMATOID; CONTRACEPTIVES, ORAL; ESTROGENS; FEMALE; HUMANS; MALE; MEDLINE; MIDDLE AGED; PROGESTERONE;

EID: 77952972980     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2010.02.003     Document Type: Review

References (33)

1. Solomon D.H., Goodson N.J., Katz J.N., et al. Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis 65 (2006) 1608-1612
2. Helmick C.G., Felson D.T., Lawrence R.C., et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States, Part I. Arthritis Rheum 58 (2008) 15-25
3. Cutolo M., and Wilder R.L. Different roles for androgens and estrogens in the susceptibility to autoimmune rheumatic diseases. Rheum Dis Clin North Am 26 (2000) 825-839
4. Cutolo M. Sex hormone adjuvant therapy in rheumatoid arthritis. Rheum Dis Clin North Am 26 (2000) 881-895
5. Ostensen M., and Villiger P.M. The remission of rheumatoid arthritis during pregnancy. Semin Immunopathol 29 (2007) 185-191
6. Hazes J.M., and Van Z.D. Oral contraception and its possible protection against rheumatoid arthritis. Ann Rheum Dis 50 (1991) 72-74
7. Pladevall-Vila M., Delclos G.L., Varas C., Guyer H., Brugues-Tarradellas J., and Anglada-Arisa A. Controversy of oral contraceptives and risk of rheumatoid arthritis: meta-analysis of conflicting studies and review of conflicting meta-analyses with special emphasis on analysis of heterogeneity. Am J Epidemiol 144 (1996) 1-14
8. Browne H., Manipalviratn S., and Armstrong A. Using an intrauterine device in immunocompromised women. Obstet Gynecol 112 (2008) 667-669
9. Morrison C.S., Sekadde-Kigondu C., Sinei S.K., Weiner D.H., Kwok C., and Kokonya D. Is the intrauterine device appropriate contraception for HIV-1-infected women?. BJOG 108 (2001) 784-790
10. Stringer E.M., Kaseba C., Levy J., et al. A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. Am J Obstet Gynecol 197 (2007) 144-148
11. World Health Organization. Medical eligibility criteria for contraceptive use. 3rd ed. (2004), World Health Organization, Geneva
12. World Health Organization. Medical eligibility criteria for contraceptive use, 2008 update Geneva, Switzerland (2008), World Health Organization [cited 2009 Jan 22]
13. Arnett F.C., Edworthy S.M., Bloch D.A., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 (1988) 315-324
14. Harris R.P., Helfand M., Woolf S.H., et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med 20 (2001) 21-35
15. Sawaya G.F., Guirguis-Blake J., LeFevre M., Harris R., and Petitti D. Update on the methods of the U.S. Preventive Services Task Force: estimating certainty and magnitude of net benefit. Ann Intern Med 147 (2007) 871-875
16. Demers R., Blais J.A., and Pretty H. Rheumatoid arthritis treated by norethynodrel associated with mestranol: clinical aspects and laboratory tests. Can Med Assoc J 95 (1966) 350-354
17. Drossaers-Bakker K.W., Zwinderman A.H., Van Z.D., Breedveld F.C., and Hazes J.M. Pregnancy and oral contraceptive use do not significantly influence outcome in long term rheumatoid arthritis. Ann Rheum Dis 61 (2002) 405-408
18. Gilbert M., Rotstein J., Cunningham C., Estrin I., Davidson A., and Pincus G. Norethynodrel with mestranol in treatment of rheumatoid arthritis. JAMA 190 (1964) 235
19. Gill D. Rheumatic complaints of women using anti-ovulatory drugs. An evaluation. J Chronic Dis 21 (1968) 435-444
20. Hazes J.M., Dijkmans B.A., Vandenbroucke J.P., and Cats A. Oral contraceptive treatment for rheumatoid arthritis: an open study in 10 female patients. Br J Rheumatol 28 (Suppl) 1 (1989) 28-30
21. Ostensen M., Aune B., and Husby G. Effect of pregnancy and hormonal changes on the activity of rheumatoid arthritis. Scand J Rheumatol 12 (1983) 69-72
22. Vignos P.J., and Dorfman R.I. Effect of large doses of progesterone in rheumatoid arthritis. Am J Med Sci 222 (1951) 29-34
23. Bijlsma J.W., Huber-Bruning O., and Thijssen J.H. Effect of oestrogen treatment on clinical and laboratory manifestations of rheumatoid arthritis. Ann Rheum Dis 46 (1987) 777-779
24. Sammaritano L.R. Therapy insight: guidelines for selection of contraception in women with rheumatic diseases. Nat Clin Pract Rheumatol 3 (2007) 273-281
25. van Vollenhoven R.F., and McGuire J.L. Estrogen, progesterone, and testosterone: can they be used to treat autoimmune diseases?. Cleve Clin J Med 61 (1994) 276-284
26. Neinstein L.S., and Katz B. Connective tissue diseases, arthritis require special patient counseling. Contracept Technol Update 6 (1985) 100-102
27. Lautenbach G.L., and Petri M. Women's health. Rheum Dis Clin North Am 25 (1999) 539-565
28. Doran M.F., Crowson C.S., Pond G.R., O'Fallon W.M., and Gabriel S.E. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 46 (2002) 2287-2293
29. van Albada-Kuipers G.A., Linthorst J., Peeters E.A., et al. Frequency of infection among patients with rheumatoid arthritis versus patients with osteoarthritis or soft tissue rheumatism. Arthritis Rheum 31 (1988) 667-671
30. Vandenbroucke J.P., Kaaks R., Valkenburg H.A., et al. Frequency of infections among rheumatoid arthritis patients, before and after disease onset. Arthritis Rheum 30 (1987) 810-813
31. Gourlay M.L., and Brown S.A. Clinical considerations in premenopausal osteoporosis. Arch Intern Med 164 (2004) 603-614
32. Haugeberg G., Orstavik R.E., and Kvien T.K. Effects of rheumatoid arthritis on bone. Curr Opin Rheumatol 15 (2003) 469-475
33. Curtis K.M., and Martins S.L. Progestogen-only contraception and bone mineral density: a systematic review. Contraception 73 (2006) 470-487